Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report

We present the case of a 24-year-old Caucasian man, who developed a scaly erythematous skin rash after the second dose of coronavirus disease 2019 (COVID-19) vaccination with Comirnaty (BNT162b2, BioNTech/Pfizer; Pfizer, New York, NY, USA) and proved positive for Epstein-Barr virus (EBV) reactivatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Herzum, Astrid, Trave, Ilaria, D’Agostino, Federica, Burlando, Martina, Cozzani, Emanuele, Parodi, Aurora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2022
Materias:
COVID-19 Special
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200649/
https://www.ncbi.nlm.nih.gov/pubmed/35799871
http://dx.doi.org/10.7774/cevr.2022.11.2.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200649/
https://www.ncbi.nlm.nih.gov/pubmed/35799871
http://dx.doi.org/10.7774/cevr.2022.11.2.222

Ejemplares similares